Sanjibon Diagnostic & Health Care Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 17-12-2024
- Paid Up Capital ₹ 5.00 M
as on 17-12-2024
- Company Age 27 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.14 Cr
as on 17-12-2024
- Satisfied Charges ₹ 1.46 M
as on 17-12-2024
- Revenue -37.18%
(FY 2023)
- Profit -4636.61%
(FY 2023)
- Ebitda -571.51%
(FY 2023)
- Net Worth -87.51%
(FY 2023)
- Total Assets -41.56%
(FY 2023)
About Sanjibon Diagnostic & Health Care
The Corporate was formerly known as Sanjibon Diagnostic & Medical Research Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹2.14 Cr. The company has closed loans amounting to ₹1.46 M, as per Ministry of Corporate Affairs (MCA) records.
Tapati Ray, Pradeep Paul, and Aditya Ruhil serve as directors at the Company.
- CIN/LLPIN
U85195WB1997PTC085179
- Company No.
085179
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Aug 1997
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Sanjibon Diagnostic & Health Care?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Tapati Ray | Director | 14-Aug-1997 | Current |
Pradeep Paul | Director | 14-Aug-1997 | Current |
Aditya Ruhil | Director | 14-Aug-1997 | Current |
Financial Performance of Sanjibon Diagnostic & Health Care.
Sanjibon Diagnostic & Health Care Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 37.18% decrease. The company also saw a substantial fall in profitability, with a 4636.61% decrease in profit. The company's net worth observed a substantial decline by a decrease of 87.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Sanjibon Diagnostic & Health Care?
Unlock access to Sanjibon Diagnostic & Health Care's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Jrg Automotive Industries India Private LimitedActive 12 years 1 month
Aditya Ruhil is a mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 29 Apr 2020 | ₹0.77 M | Open |
United Bank Of India Creation Date: 12 Mar 2005 | ₹2.06 Cr | Open |
Abn Amro Bank N.V Creation Date: 19 Jan 2010 | ₹1.46 M | Satisfied |
How Many Employees Work at Sanjibon Diagnostic & Health Care?
Sanjibon Diagnostic & Health Care has a workforce of 36 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanjibon Diagnostic & Health Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanjibon Diagnostic & Health Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.